Clinical Trial Update: Efficacy and Safety of Sofosbuvir+Ribavirin in Genotype 2 HCV-infected U.S. Veterans With Cirrhosis [Phase 4]

View source ↗

Summary

A Phase 4 trial update on the efficacy and safety of sofosbuvir plus ribavirin in genotype 2 hepatitis C patients with cirrhosis, conducted in U.S. veterans, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C Virus Infection | Phase 4 | Status: COMPLETED | Results posted: 2016-08-03